Estrella Immunopharma, Inc.(ESLA)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Estrella Immunopharma, Inc. (ESLA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ESLA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of ESLA by reported 13-F value include ARMISTICE CAPITAL, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. ESLA trades on the Nasdaq exchange and files with the SEC under CIK 1844417. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ESLA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Estrella Immunopharma, Inc. directly from SEC EDGAR.

Institutions holding ESLA

Institutional investors reporting a position in Estrella Immunopharma, Inc. on SEC Form 13F.
InstitutionSharesValueReported
ARMISTICE CAPITAL3,975,220$4.1M2026-06-30
VANGUARD CAPITAL MANAGEMENT416,852$433.5K2026-06-30
GEODE CAPITAL MANAGEMENT141,321$147.0K2026-06-30
VANGUARD FIDUCIARY64,921$67.5K2026-06-30
BlackRock52,033$54.1K2026-06-30
STATE STREET43,252$45.0K2026-06-30
RENAISSANCE TECHNOLOGIES39,100$40.7K2026-06-30
NORTHERN34,861$36.3K2026-06-30
US BANCORP \DE\20,000$20.8K2026-06-30
Tower Research Capital (TRC)3,308$3.4K2026-06-30
SEC EDGAR: CIK 1844417 →
ESLA

Estrella Immunopharma, Inc.

ESLA
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Top Institutional Holders

as of Q2 2026
$4.99M total
ARMISTICE CAPITAL, LLC
$4.13M-3.0%
VANGUARD CAPITAL MANAGEMENT LLC
$433.5K+9.0%
GEODE CAPITAL MANAGEMENT, LLC
$147.0K-10.3%
VANGUARD FIDUCIARY TRUST CO
$67.5K0.0%
BlackRock, Inc.
$54.1K+30.4%
STATE STREET CORP
$45.0K0.0%
RENAISSANCE TECHNOLOGIES LLC
$40.7K-37.7%
NORTHERN TRUST CORP
$36.3K+77.6%
US BANCORP \DE\
$20.8K+18.3%
Tower Research Capital LLC (TRC)
$3.4K-31.9%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…